Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: Results from the randomized BFORE trial

1. Cortes, J.E.
2. Gambacorti-Passerini, C.
3. Deininger, M.W.
4. Mauro, M.J.
5. Chuah, C.
6. Kim, D.-W.
7. Dyagil, I.
8. Glushko, N.
9. Milojkovic, D.
10. Le Coutre, P.
11. Garcia-Gutierrez, V.
12. Reilly, L.
13. Jeynes-Ellis, A.
14. Leip, E.
15. Bardy-Bouxin, N.
16. Hochhaus, A.
17. Brümmendorf, T.H.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1200/JCO.2017.74.7162 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus